Skip to content

Clinical trials

Phase 3 Thrombosis trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Thrombosis Phase: Phase 3 Country / region: Italy Clear all

15 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20021
20041
20062
20071
20081
20092
20101
20142
20181
20202
20211

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed10
Terminated3
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Sanofi3
ASST Fatebenefratelli Sacco1
Assistance Publique - Hôpitaux de Paris1
AstraZeneca1
Azienda Ospedaliera Universitaria Integrata Verona1
Bayer1
Consorzio Mario Negri Sud1
Daiichi Sankyo1
GlaxoSmithKline1
Ottawa Hospital Research Institute1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Thrombosis15
Venous Thrombosis4
Pulmonary Embolism3
Venous Thromboembolism3
COVID-192
Heart Defects, Congenital2
Thromboembolism2
Acute Coronary Syndrome1
Antiphospholipid Syndrome1
Cardiovascular Diseases1

Trials

Showing 1 to 15 of 15. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.